Cronin has worked at Moderna since 2021, when she was brought on to market the biotech company’s COVID-19 vaccine.

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

When it comes to innovation, location matters. Because of Trump, China's dominance of the world economy could be nigh.

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...

Fusing a world-class ecosystem with cutting-edge technology, the UK is setting a new standard for innovation in life sciences ...

Moderna has said it will open a new R&D and ... but could be in the 'golden triangle' that extends between London, Oxford and Cambridge and encompasses the UK's main biopharma cluster, or possibly ...

Hello and welcome to the newsletter, a grab bag of daily content from the Odd Lots universe. Sometimes it's us, Joe ...

Just a few years since pioneering a Covid-19 vaccine, Moderna faces a hostile political environment and a looming patent problem. We recently compiled a list of the 12 Most Promising Biotech ...

Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...